YPL-001 significantly inhibited TNF-induced MUC5AC secretion (Figure 1B, arrowhead) in a dose-dependent manner (Figure 1B, asterisks), suggesting that YPL-001 suppresses COPD-associated mucus hypersecretion in human airway cells. This evidence concerns the gene TNF and chronic obstructive pulmonary disease.